SALAGEN

This brand name is authorized in United States. It is also authorized in Austria, Canada, Estonia, Finland, France, Israel, Japan, Malta, Netherlands, Singapore, Spain, Turkey, UK.

Active ingredients

The drug SALAGEN contains one active pharmaceutical ingredient (API):

1	Pilocarpine UNII 0WW6D218XJ - PILOCARPINE HYDROCHLORIDE
	Pilocarpine is a cholinergic parasympathomimetic agent exerting a broad spectrum of pharmacologic effects with predominant muscarinic action. Pilocarpine, in appropriate dosage, can increase secretion by exocrine glands such as the sweat, salivary, lacrimal, gastric, pancreatic and intestinal glands and the mucous cells of the respiratory tract.
	Read more about Pilocarpine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SALAGEN Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N07AX01	Pilocarpine	N Nervous system → N07 Other nervous system drugs → N07A Parasympathomimetics → N07AX Other parasympathomimetics
Discover more medicines within N07AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02216345
EE	Ravimiamet	1809772, 1852499
ES	Centro de información online de medicamentos de la AEMPS	61835
FI	Lääkealan turvallisuus- ja kehittämiskeskus	025700
FR	Base de données publique des médicaments	67995282
GB	Medicines & Healthcare Products Regulatory Agency	38947
IL	מִשְׂרַד הַבְּרִיאוּת	3255
JP	医薬品医療機器総合機構	2399013D1020, 2399013F1021
MT	Medicines Authority	AA565/28004
NL	Z-Index G-Standaard, PRK	57843
SG	Health Sciences Authority	11683P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699587094186
US	FDA, National Drug Code	59212-705, 59212-775, 62856-705, 62856-775